ATE238775T1 - Entzündungshemmende pharmazeutische formulierungen - Google Patents

Entzündungshemmende pharmazeutische formulierungen

Info

Publication number
ATE238775T1
ATE238775T1 AT99944682T AT99944682T ATE238775T1 AT E238775 T1 ATE238775 T1 AT E238775T1 AT 99944682 T AT99944682 T AT 99944682T AT 99944682 T AT99944682 T AT 99944682T AT E238775 T1 ATE238775 T1 AT E238775T1
Authority
AT
Austria
Prior art keywords
pharmaceutical formulations
inflammatory pharmaceutical
mixture
inflammatory
nsaid
Prior art date
Application number
AT99944682T
Other languages
English (en)
Inventor
John Woolfe Austin
Gordon Mcintyre
Nitin Vadilal Sheth
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Application granted granted Critical
Publication of ATE238775T1 publication Critical patent/ATE238775T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99944682T 1998-09-10 1999-09-10 Entzündungshemmende pharmazeutische formulierungen ATE238775T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9819685.0A GB9819685D0 (en) 1998-09-10 1998-09-10 Anti-inflammatory pharmaceutical formulations
PCT/GB1999/002831 WO2000015200A1 (en) 1998-09-10 1999-09-10 Anti-inflammatory pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ATE238775T1 true ATE238775T1 (de) 2003-05-15

Family

ID=10838600

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944682T ATE238775T1 (de) 1998-09-10 1999-09-10 Entzündungshemmende pharmazeutische formulierungen

Country Status (9)

Country Link
EP (1) EP1109538B1 (de)
AT (1) ATE238775T1 (de)
AU (1) AU5750799A (de)
DE (1) DE69907481T2 (de)
DK (1) DK1109538T3 (de)
ES (1) ES2198956T3 (de)
GB (1) GB9819685D0 (de)
PT (1) PT1109538E (de)
WO (1) WO2000015200A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319519B2 (en) 1998-07-07 2001-11-20 Norton Healthcare Ltd. Anti-inflammatory pharmaceutical formulations
US6387410B1 (en) 1998-09-10 2002-05-14 Norton Healthcare Ltd Anti-inflammatory pharmaceutical formulations
US6183779B1 (en) 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
EP1216030A1 (de) * 1999-10-01 2002-06-26 Norton Healthcare Limited Entzündungshemmende pharmazeutische formulierungen
US20090022786A1 (en) * 2007-07-16 2009-01-22 Yung Shin Pharm. Ind. Co., Ltd. Oral pharmaceutical dosage form and manufacturing method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016895A1 (en) * 1990-05-03 1991-11-14 G.D. Searle & Co. Pharmaceutical composition
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
CN1277550A (zh) * 1997-09-11 2000-12-20 尼科梅德丹麦有限公司 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物

Also Published As

Publication number Publication date
DE69907481D1 (de) 2003-06-05
GB9819685D0 (en) 1998-11-04
EP1109538A1 (de) 2001-06-27
AU5750799A (en) 2000-04-03
WO2000015200A1 (en) 2000-03-23
ES2198956T3 (es) 2004-02-01
DK1109538T3 (da) 2003-08-25
PT1109538E (pt) 2003-09-30
EP1109538B1 (de) 2003-05-02
DE69907481T2 (de) 2004-03-11

Similar Documents

Publication Publication Date Title
DE69819351D1 (de) Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids)
CY1105170T1 (el) Συνταγοποιηση απο του στοματος δοσολογιας αστραπιαιας - τηξης
AP1954A (en) Controlled release compositions comprising nimesulide.
NO20011471D0 (no) Nye orale vedvarende frigivelsesformuleringer
DK1276467T3 (da) Formuleringer og tabletter til forhalet frigivelse af guaifenesin
CL2009001682A1 (es) Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
UA84266C2 (uk) Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
ES2042541T3 (es) Un procedimiento de preparacion de una formulacion farmaceutica de liberacion retardada que contiene goma de xantano.
ES2161690T3 (es) Formulaciones farmaceuticas.
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
UY27553A1 (es) Formulaciones farmacéuticas de 5,7,14-triazatetraciclo(10.3.1.02,11.04,9)-hexadeca-2/11),3,5,7,9-pentaeno
CY1106072T1 (el) Φαρμακευτικη μορφη δοσης παρατεταμενης αποδεσμευσης απο του στοματος
CY1112260T1 (el) Σκευασματα υδροκωδονης ελεγχομενης απελευθερωσης
MX9804008A (es) Formulaciones farmaceuticas.
AR034691A1 (es) Composiciones farmaceuticas de administracion oral, que contiene un inhibidor de lipasa gastrointestinal, el comprimido masticable y la galleta que los comprende
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
MX9701342A (es) Formulacion cosolvente de tirilazad para administracion parenteral.
DK1365749T3 (da) Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til anvendelse i blöde gelformuleringer
ES2160145T3 (es) Composicion farmaceutica para la administracion oral de flavonoides.
AR011919A1 (es) FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA
FI951357L (fi) Farmaseuttiset koostumukset, jotka mahdollistavat trimetatsidiinin hidastetun vapautumisen oraalisen annostuksen jälkeen
SE9700885D0 (sv) New pharmaceutical formulation
ATE304844T1 (de) Entzündungshemmende pharmazeutische formulierungen
DE69907481D1 (de) Entzündungshemmende pharmazeutische formulierungen
NO20032581D0 (no) Farmasöytisk formulering av gepiron for oral administrering

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1109538

Country of ref document: EP

REN Ceased due to non-payment of the annual fee